Botox® Vs Dysport® — Which One Is Better?
(Taken from: http://www.californiasurgicalinstitute.com/blog/botox-vs-dysport%E2%80%94which-one-is-better.html)
Cosmetic Surgery Products, Face Lift, Skin Care, Wrinkle Removal
Botox® injection is currently the most popular non-surgical cosmetic procedure in the US. While previously used for excessive blinking and certain muscle disorders, the Food and Drug Administration in 2002 has approved its use for wrinkle treatment especially for the crow’s feet, forehead lines, and creases between the eyebrows.
In 2009, the FDA has approved another wrinkle treatment called Dysport® which, like Botox®, is derived from a protein produced by the bacterium Clostridium botulinum. They are both toxin compounds that are reasonably safe if used in small doses.
Just recently, a study conducted by two scientists from the University of California has revealed that Dysport® provided better results than Botox® particularly in terms of removing the crow’s feet or what plastic surgeons refer to as the “lateral orbital rhytids.”
(Injection Site for Dysport® – Medicsi Website)
The study involved 90 patients who received Botox® from one side of their face and Dysport® from the other. The respondents and their doctors said that while there was no significant difference between the results of the treatments when the facial muscles were at rest, majority of them stated that Dysport was overall better than its rival.
In 2010, Botox® was the most commonly performed non-invasive cosmetic procedure, with about 5.4 millions treatments or 12 percent increase from the previous year. In addition, male patients, who are often reluctant to undergo surgical techniques unlike women, find this particularly appealing, a separate study found.
The researchers used a 5-point scale to evaluate each patient’s appearance. Meanwhile, the respondents included in the study were asked to squeeze and contract their facial muscles as much as possible and rate their satisfaction from what they were seeing. According to the finding, about 67 percent said they preferred Dysport® results compared to 33 percent who favored Botox® injection.
But when the facial muscles were relaxed, the participants and researchers were unable to differentiate the results from both the treatments.
With the findings, the researchers concluded that Dysport® “is superior in treating lateral orbital rhytids than Botox®,” although “more studies should be conducted in order to compare the two products in addressing other muscle groups in the face.”
Meanwhile, Botox® and Dysport® are both botulinum toxin which can paralyze and relax the facial muscles, and affect the nerve impulses in order to prevent expression lines.
The researchers said they approached Allergan Inc, makers of Botox®, and Medicis Aesthetics Inc., makers of Dysport®, for the study’s funding. Only the latter provided financial sponsorship.